{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:26:14Z","timestamp":1761859574743,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jnma.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:34:24Z","timestamp":1653957264000},"page":"S20-S24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["Chronic kidney disease and vaccinations\u2013A practical guide for primary care providers"],"prefix":"10.1016","volume":"114","author":[{"given":"Denise","family":"Thomson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Stang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itunu","family":"Owoyemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jnma.2022.05.003_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.ackd.2019.01.004","article-title":"Immune dysfunction and risk of infection in chronic kidney disease","volume":"26","author":"Syed-Ahmed","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"year":"2021","series-title":"Annual Report. Last Assessed on April 4, 2022","key":"10.1016\/j.jnma.2022.05.003_bib0002"},{"issue":"7","key":"10.1016\/j.jnma.2022.05.003_bib0003","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/toxins12070439","article-title":"Immune dysfunction in Uremia 2020","volume":"12","author":"Cohen","year":"2020","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.jnma.2022.05.003_bib0004","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of Recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the advisory committee on immunization practices - United States, 2022","volume":"71","author":"Anderson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.jnma.2022.05.003_bib0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cid\/ciz177","article-title":"Immunogenicity and safety of the adjuvanted recombinant Zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial","volume":"70","author":"Vink","year":"2020","journal-title":"Clin Infectious Dis: Official Publ Infect Dis Soc Am"},{"issue":"5","key":"10.1016\/j.jnma.2022.05.003_bib0006","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.semnephrol.2016.05.016","article-title":"Human Papillomavirus in kidney transplant recipients","volume":"36","author":"Chin-Hong","year":"2016","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1016\/j.jnma.2022.05.003_bib0007","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1053\/j.ajkd.2020.11.017","article-title":"KDOQI US commentary on the 2020 KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation","volume":"77","author":"Puttarajappa","year":"2021","journal-title":"Am J Kidney Dis: the Off J Natl Kidney Found"},{"issue":"6","key":"10.1016\/j.jnma.2022.05.003_bib0008","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/517952","article-title":"Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient","volume":"28","author":"Kamboj","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.jnma.2022.05.003_bib0009","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.vaccine.2017.12.038","article-title":"Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jnma.2022.05.003_bib0010","unstructured":"Centers for Disease Control. Guidelines for vaccinating kidney dialyisis patients and patients with chronic kidney disease. Summary of ACIP Recommendations, 2012."},{"issue":"25","key":"10.1016\/j.jnma.2022.05.003_bib0011","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.vaccine.2021.05.003","article-title":"An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B\u00ae) in adults receiving hemodialysis","volume":"39","author":"Awad","year":"2021","journal-title":"Vaccine"},{"issue":"7821","key":"10.1016\/j.jnma.2022.05.003_bib0012","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jnma.2022.05.003_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.31749","article-title":"Immunogenicity rates after SARS-CoV-2 vaccination in people with end-stage kidney disease: a systematic review and meta-analysis","volume":"4","author":"Chen","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jnma.2022.05.003_bib0014","first-page":"1","article-title":"Meningococcal Vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR. Recommendations and reports: morbidity and mortality weekly report","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"Recomm Rep"},{"issue":"9","key":"10.1016\/j.jnma.2022.05.003_bib0015","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/ndt\/gfq798","article-title":"Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease","volume":"26","author":"Viasus","year":"2011","journal-title":"Nephrol Dial Transplant: Off Pub Eur Dial Transplant Assoc - Eur Renal Assoc"},{"key":"10.1016\/j.jnma.2022.05.003_bib0016","unstructured":"Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs): trends by serotype group. Accessed February 28, 2022."},{"issue":"25","key":"10.1016\/j.jnma.2022.05.003_bib0017","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.vaccine.2019.04.087","article-title":"Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia","volume":"37","author":"Isturiz","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jnma.2022.05.003_bib0018","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR","volume":"71","author":"Kobayashi","year":"2022","journal-title":"Morb Mortal Wkly Rep"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968422000840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968422000840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:18:56Z","timestamp":1758435536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968422000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0027968422000840"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2022.05.003","relation":{},"ISSN":["0027-9684"],"issn-type":[{"type":"print","value":"0027-9684"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic kidney disease and vaccinations\u2013A practical guide for primary care providers","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of National Medical Association.","name":"copyright","label":"Copyright"}]}}